Maximum tumor size reduction from baseline. All 26 efficacy-evaluable patients achieved tumor reduction. Tumor size was assessed by measurement of index lesions on CT scans, whereas overall response (indicated by the color of the bars) was based on the Revised Response Criteria for Malignant Lymphoma,¹⁸  which incorporates both CT and PET scan results.